U.S. Food and Drug Administration (FDA)

GPTKB entity

Statements (103)
Predicate Object
gptkbp:instanceOf gptkb:government_agency
gptkbp:abbreviation gptkb:FDA
gptkbp:budget over $6 billion
gptkbp:commissioner gptkb:Robert_M._Califf
gptkbp:country gptkb:United_States
gptkbp:employs over 17,000 people
gptkbp:founded 1906
gptkbp:hasDivision gptkb:Center_for_Biologics_Evaluation_and_Research_(CBER)
gptkb:Center_for_Devices_and_Radiological_Health_(CDRH)
gptkb:Center_for_Drug_Evaluation_and_Research_(CDER)
gptkb:Center_for_Food_Safety_and_Applied_Nutrition_(CFSAN)
gptkb:Center_for_Tobacco_Products_(CTP)
gptkb:Center_for_Veterinary_Medicine_(CVM)
gptkb:National_Center_for_Toxicological_Research_(NCTR)
gptkb:Office_of_Regulatory_Affairs_(ORA)
gptkb:Office_of_the_Commissioner
gptkbp:headquartersLocation gptkb:Silver_Spring,_Maryland
https://www.w3.org/2000/01/rdf-schema#label U.S. Food and Drug Administration (FDA)
gptkbp:jurisdiction gptkb:federal_government_of_the_United_States
gptkbp:oversees gptkb:510(k)_premarket_notification_for_medical_devices
gptkb:ANDA_(Abbreviated_New_Drug_Application)
gptkb:Accelerated_Approval_pathway
gptkb:Animal_Drug_User_Fee_Act_(ADUFA)
gptkb:Biologics_License_Applications_(BLA)
gptkb:Biosimilar_User_Fee_Act_(BsUFA)
gptkb:Breakthrough_Therapy_designation
gptkb:Drug_Supply_Chain_Security_Act
gptkb:Emergency_Use_Authorization_(EUA)
gptkb:FDA_Adverse_Event_Reporting_System_(FAERS)
gptkb:Fast_Track_designation
gptkb:Food_Code
gptkb:Food_Facility_Registration
gptkb:Food_Safety_Modernization_Act_(FSMA)
gptkb:GRAS_(Generally_Recognized_as_Safe)_substances
gptkb:Generic_Drug_User_Fee_Amendments_(GDUFA)
gptkb:Good_Manufacturing_Practice_(GMP)_regulations
gptkb:Investigational_New_Drug_(IND)_applications
gptkb:Medical_Device_User_Fee_Amendments_(MDUFA)
gptkb:New_Drug_Applications_(NDA)
gptkb:Nutrition_Facts_label
gptkb:Orphan_Drug_Act
gptkb:Orphan_Drug_designation
gptkb:Premarket_Approval_(PMA)_for_medical_devices
gptkb:Prescription_Drug_User_Fee_Act_(PDUFA)
gptkb:Priority_Review_designation
gptkb:Rare_Pediatric_Disease_Priority_Review_Voucher
gptkb:Risk_Evaluation_and_Mitigation_Strategies_(REMS)
gptkb:Vaccine_Adverse_Event_Reporting_System_(VAERS)
Biologics Approval Process
ClinicalTrials.gov registration
Cosmetic Regulation
Drug Approval Process
Expanded Access (compassionate use) programs
Food Additive Approval Process
Food labeling regulations
MedWatch safety information
Medical Device Approval Process
Pediatric exclusivity
Tobacco Product Regulation
Veterinary Product Regulation
gptkbp:parentOrganization gptkb:U.S._Department_of_Health_and_Human_Services
gptkbp:regulates gptkb:livestock
clinical trials
animal drugs
biologics
biosimilars
blood products
color additives
compounded drugs
food additives
food contact substances
food labeling
generic drugs
infant formula
mammography facilities
orphan drugs
over-the-counter drugs
prescription drugs
medical device
tobacco manufacturing
drug recalls
food recalls
medical device recalls
radiation-emitting electronic products
biologic recalls
cosmetic recalls
dietary supplement recalls
tobacco recalls
vaccine recalls
veterinary product recalls
gptkbp:responsibleFor regulation of cosmetics
regulation of dietary supplements
regulation of medical devices
regulation of tobacco products
regulation of vaccines
regulation of veterinary products
regulation of food safety
regulation of pharmaceuticals
gptkbp:website https://www.fda.gov/
gptkbp:bfsParent gptkb:Philip_Morris_USA
gptkb:Rockville,_Maryland,_United_States
gptkb:positron_emission_tomography_(PET)_imaging
gptkbp:bfsLayer 6